Advertisement

Rituximab causes a polarisation of B cells which augments its therapeutic function in NK cell-mediated antibody-dependent cellular cytotoxicity

Dominika Rudnicka, Anna Oszmiana, Donna K. Finch, Ian Strickland, Darren J. Schofield, David C. Lowe, Matthew A. Sleeman, Daniel M. Davis